Coagulation factorV and thrombophilia:: Background and mechanisms

被引:124
作者
Segers, Kenneth
Dahlback, Bjorn
Nicolaes, Gerry A. F. [1 ]
机构
[1] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands
[2] Lund Univ, Univ Hosp, Wallenberg Lab, Dept Lab Med, Malmo, Sweden
关键词
factorV; coagulation; thrombosis; thrombophilia; protein C pathway;
D O I
10.1160/TH07-02-0150
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human coagulation factorV (FV) is an essential coagulation protein with functions in both the pro- and anticoagulant pathways. Failure to express and control FV functions can either lead to bleeding, or to thromboembolic disease. Both events may develop into a life-threatening condition. Since the first description of APC resistance, and in particular the description of the so-called factorV(Leiden) mutation, in which a prominent activated protein C cleavage site in FV has been abolished through a mutation in the FV gene,FV has been in the center of attention of thrombosis research. In this review we describe ow the functions of FV are expressed and regulated and provide an extensive description of the role that FV plays in the etiology of thromboembolic disease.
引用
收藏
页码:530 / 542
页数:13
相关论文
共 161 条
[41]   Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex [J].
Fuentes-Prior, P ;
Iwanaga, Y ;
Huber, R ;
Pagila, R ;
Rumennik, G ;
Seto, M ;
Morser, J ;
Light, DR ;
Bode, W .
NATURE, 2000, 404 (6777) :518-525
[42]  
FULCHER CA, 1983, BLOOD, V61, P807
[43]   FACTOR-XI ACTIVATION IN A REVISED MODEL OF BLOOD-COAGULATION [J].
GAILANI, D ;
BROZE, GJ .
SCIENCE, 1991, 253 (5022) :909-912
[44]   Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C [J].
Gale, AJ ;
Xu, X ;
Pellequer, JL ;
Getzoff, ED ;
Griffin, JH .
PROTEIN SCIENCE, 2002, 11 (09) :2091-2101
[45]   Molecular characterization of an extended binding site for coagulation factor Va in the positive exosite of activated protein C [J].
Gale, AJ ;
Tsavaler, A ;
Griffin, JH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (32) :28836-28840
[46]   INCIDENCE OF ACTIVATED PROTEIN-C RESISTANCE CAUSED BY THE ARG-506 GLN MUTATION IN FACTOR-V IN 113 UNRELATED SYMPTOMATIC PROTEIN C-DEFICIENT PATIENTS [J].
GANDRILLE, S ;
GREENGARD, JS ;
ALHENCGELAS, M ;
JUHANVAGUE, I ;
ABGRALL, JF ;
JUDE, B ;
GRIFFIN, JH ;
AIACH, M .
BLOOD, 1995, 86 (01) :219-224
[47]   FIBRIN GLUE - THE PERFECT OPERATIVE SEALANT [J].
GIBBLE, JW ;
NESS, PM .
TRANSFUSION, 1990, 30 (08) :741-747
[48]   ACTIVATED PROTEIN-C RESISTANCE CAUSED BY ARG506GLN MUTATION IN FACTOR VA [J].
GREENGARD, JS ;
SUN, X ;
XU, X ;
FERNANDEZ, JA ;
GRIFFIN, JH ;
EVATT, B .
LANCET, 1994, 343 (8909) :1361-1362
[49]   DEFICIENCY OF PROTEIN-C IN CONGENITAL THROMBOTIC DISEASE [J].
GRIFFIN, JH ;
EVATT, B ;
ZIMMERMAN, TS ;
KLEISS, AJ ;
WIDEMAN, C .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (05) :1370-1373
[50]   Amino acid residues in thrombin-sensitive region and first epidermal growth factor domain of vitamin K-dependent protein S determining specificity of the activated protein C cofactor function [J].
He, XH ;
Shen, L ;
Villoutreix, BO ;
Dahlbäck, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (42) :27449-27458